MeSH tree: C04.557
Seventy-five percent of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) who were treated with the antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) had a complete response, according to new data from ...
2 hours ago
0
0
A new study from the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds that pleurectomy/decortication, a lung-sparing surgery, can be performed safely with low mortality in carefully selected ...
4 hours ago
0
0
Meningioma is the most common type of brain tumor. It does not develop in the brain tissue itself, but on the inside of the meninges, the membranes that surround the brain. In most cases, a meningioma is benign. However, ...
Feb 11, 2026
0
0
A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors' ability to evade attack by the body's immune system, a new study shows. Led by researchers at NYU Langone Health and ...
Feb 11, 2026
0
0
Lung cancer patients who have never smoked make up a significant and growing share of global lung cancer cases, yet remain an understudied group, according to a new review written by UCL (University College London) researchers.
Feb 11, 2026
0
0
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has shown that a single injection of an oncolytic virus—a genetically modified virus that selectively infects and destroys cancer cells—can ...
Feb 11, 2026
0
80
Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune cells recognize gradually ...
Feb 11, 2026
0
0
For the first time, researchers have identified a previously unrecognized metabolic defense mechanism in aggressive brain tumors: a sugar-rich shield that surrounds tumor cells and protects them against a particularly destructive ...
Feb 11, 2026
0
0
Researchers at The University of Texas MD Anderson Cancer Center have identified blood-based biomarkers that can help distinguish patients with glioblastoma who are most likely to live longer from novel treatment with an ...
Feb 11, 2026
0
0
Edward (Ed) Waldner had no idea why he didn't feel well, but he knew he didn't feel like himself. At 55 years of age, he felt exhausted all the time. It didn't seem to matter how hard he had worked that day. He wondered if ...
Feb 10, 2026
0
15
